BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23144955)

  • 1. Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer's disease.
    Silva AR; Grinberg LT; Farfel JM; Diniz BS; Lima LA; Silva PJ; Ferretti RE; Rocha RM; Filho WJ; Carraro DM; Brentani H
    PLoS One; 2012; 7(11):e48751. PubMed ID: 23144955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease.
    Silva AR; Santos AC; Farfel JM; Grinberg LT; Ferretti RE; Campos AH; Cunha IW; Begnami MD; Rocha RM; Carraro DM; de Bragança Pereira CA; Jacob-Filho W; Brentani H
    PLoS One; 2014; 9(6):e99897. PubMed ID: 24936870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
    Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
    Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle checkpoint abnormalities during dementia: A plausible association with the loss of protection against oxidative stress in Alzheimer's disease [corrected].
    Katsel P; Tan W; Fam P; Purohit DP; Haroutunian V
    PLoS One; 2013; 8(7):e68361. PubMed ID: 23861893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease.
    Galea E; Weinstock LD; Larramona-Arcas R; Pybus AF; Giménez-Llort L; Escartin C; Wood LB
    Neurobiol Dis; 2022 May; 166():105655. PubMed ID: 35143967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology.
    Liang WS; Dunckley T; Beach TG; Grover A; Mastroeni D; Ramsey K; Caselli RJ; Kukull WA; McKeel D; Morris JC; Hulette CM; Schmechel D; Reiman EM; Rogers J; Stephan DA
    Neurobiol Aging; 2010 Apr; 31(4):549-66. PubMed ID: 18572275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Gene and Protein Expression Reveals Perturbed Functional Networks in Alzheimer's Disease.
    Canchi S; Raao B; Masliah D; Rosenthal SB; Sasik R; Fisch KM; De Jager PL; Bennett DA; Rissman RA
    Cell Rep; 2019 Jul; 28(4):1103-1116.e4. PubMed ID: 31340147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia.
    Haroutunian V; Katsel P; Schmeidler J
    Neurobiol Aging; 2009 Apr; 30(4):561-73. PubMed ID: 17845826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
    PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer's disease.
    Lin CX; Li HD; Deng C; Liu W; Erhardt S; Wu FX; Zhao XM; Guan Y; Wang J; Wang D; Hu B; Wang J
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34953465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.
    Barroeta-Espar I; Weinstock LD; Perez-Nievas BG; Meltzer AC; Siao Tick Chong M; Amaral AC; Murray ME; Moulder KL; Morris JC; Cairns NJ; Parisi JE; Lowe VJ; Petersen RC; Kofler J; Ikonomovic MD; López O; Klunk WE; Mayeux RP; Frosch MP; Wood LB; Gomez-Isla T
    Neurobiol Dis; 2019 Jan; 121():327-337. PubMed ID: 30336198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic analysis of probable asymptomatic and symptomatic alzheimer brains.
    Patel H; Hodges AK; Curtis C; Lee SH; Troakes C; Dobson RJB; Newhouse SJ
    Brain Behav Immun; 2019 Aug; 80():644-656. PubMed ID: 31063847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
    Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
    Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered DNA base excision repair profile in brain tissue and blood in Alzheimer's disease.
    Lillenes MS; Rabano A; Støen M; Riaz T; Misaghian D; Møllersen L; Esbensen Y; Günther CC; Selnes P; Stenset VT; Fladby T; Tønjum T
    Mol Brain; 2016 May; 9(1):61. PubMed ID: 27234294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A third of community-dwelling elderly with intermediate and high level of Alzheimer's neuropathologic changes are not demented: A meta-analysis.
    Azarpazhooh MR; Avan A; Cipriano LE; Munoz DG; Erfanian M; Amiri A; Stranges S; Hachinski V
    Ageing Res Rev; 2020 Mar; 58():101002. PubMed ID: 31899366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia.
    Pasinetti GM
    J Neurosci Res; 2001 Sep; 65(6):471-6. PubMed ID: 11550214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revealing the Molecular Mechanisms of Alzheimer's Disease Based on Network Analysis.
    Bayraktar A; Lam S; Altay O; Li X; Yuan M; Zhang C; Arif M; Turkez H; Uhlén M; Shoaie S; Mardinoglu A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive composite score association with Alzheimer's disease plaque and tangle pathology.
    Malek-Ahmadi M; Chen K; Perez SE; He A; Mufson EJ
    Alzheimers Res Ther; 2018 Sep; 10(1):90. PubMed ID: 30205840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.
    Mirra SS; Heyman A; McKeel D; Sumi SM; Crain BJ; Brownlee LM; Vogel FS; Hughes JP; van Belle G; Berg L
    Neurology; 1991 Apr; 41(4):479-86. PubMed ID: 2011243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.